1. India Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited

8.93
INR
-0.47
(-5.00%)
-0.21EPS
646.31MMarket Cap
JHS Svendgaard Laboratories Limited
BSE:JHS
(Bombay Stock Exchange)

Recent

price

8.93

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
87.76
74.88
24.73
14.61
22.96
38.96
25.9
24.58
20.24
22.74
16.3
13.26
10.73
8.9
10.98
11.73
11.99
Revenue per Share
8.39
0.66
-1.56
-11.96
-9.2
-8.42
5.45
4.62
-0.11
-0.32
0.2
-0.63
-2.23
-0.52
-2.37
-0.22
-0.21
Basic EPS, GAAP
-0.82
-22.46
18.56
11.51
3.03
-2.62
-4.18
0.52
-4.33
-0.6
0.6
-2.46
1.14
-5.19
-1.89
-1.8
- -
Free Cash Flow per Basic Share
0.65
0.75
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
58.13
65.34
37.12
25.77
49.71
26.75
30.46
28.61
29.04
29.23
29.3
28.64
25.57
21.67
20.18
19.98
- -
Book Value per Share
57.96
65.25
37.08
25.74
49.65
26.72
30.44
28.6
28.84
29.04
29.12
28.47
25.45
21.23
19.79
19.68
- -
Tangible Book Value per Share
15
17
24
24
24
26
40
57
61
61
61
64
78
78
83
86
91
Basic Weighted Avg Shares
1,277
1,266
596
352
553
1,001
1,042
1,390
1,233
1,385
1,001
855
841
698
913
1,007
1,086
Sales/Revenue/Turnover
-7.52
6.83
-3.07
-43.6
-26.56
-3.58
5.22
6.13
-1.39
-2
3.67
-5.88
-17.36
-8.98
-10.53
-3.82
-4.06
Operating Margin (%)
70
73
136
147
123
105
64
68
71
88
73
71
60
63
80
75
74
Depreciation Expense
122
11
-38
-288
-222
-216
219
261
-7
-20
12
-41
-175
-41
-197
-19
-19
Net Income, GAAP
13.42
65.97
1,314.91
- -
- -
- -
- -
32.19
- -
- -
- -
4,264.47
- -
- -
- -
- -
- -
Effective Tax Rate (%)
9.56
0.88
-6.31
-81.85
-40.09
-21.62
21.04
18.82
-0.55
-1.43
1.2
-4.74
-20.83
-5.81
-21.63
-1.91
-1.74
Profit Margin (%)
605
368
-520
-672
-63
195
229
710
629
818
978
600
481
203
287
308
- -
Working Capital
475
267
193
132
1
14
6
11
8
66
55
51
150
12
12
55
- -
LT Debt
846
1,147
895
621
1,198
1,007
1,344
1,742
1,806
1,846
1,980
1,950
1,738
1,699
1,727
1,747
- -
Total Equity
-6.72
1.92
-50.3
- -
- -
- -
- -
15.2
- -
- -
- -
103.04
- -
- -
- -
- -
- -
Return on Invested Capital (%)
12.47
2.08
-2.21
- -
- -
- -
- -
17.07
- -
- -
- -
-27.91
- -
- -
- -
- -
- -
Return on Capital (%)
15.41
1.11
-3.69
-38.02
-24.39
-19.63
18.66
16.94
-0.39
-1.12
0.65
-2.16
-9.96
-2.42
-11.53
-1.11
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
93
- -
LT Borrowings
- -
55
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
87
86
Market Capitalization
844
556
646

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
634
- -
Cash, Cash Equivalents & STI
- -
190
- -
Accounts Receivable, Net
- -
168
- -
Inventories
- -
152
- -
Total Current Liabilities
- -
326
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
93
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.44%
-2.37%
1.12%
Free Cash Flow
-255.04%
-260.82%
-1.65%
Net Income, GAAP
-14.09%
22.73%
-90.26%
Sales/Revenue/Turnover
1.87%
1.58%
10.38%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
245
197
227
252
913
2026
235
223
233
327
1,007
2027
304
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.08
-1.24
-0.21
-0.84
-2.37
2026
0.12
-0.02
0.09
-0.42
-0.22
2027
0.12
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
JHS Svendgaard Laboratories Limited manufactures and exports oral care products including toothbrushes, toothpastes, mouthwashes, denture tablets, hand sanitizers, laundry detergents, room fresheners, and talcum powder; it provides contract manufacturing services for domestic and international brands such as Hindustan Unilever, Amway, Walmart, Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Dabur, Apollo Pharmacy, and Gillette's Oral-B. The company operates ISO-certified facilities in Kala Amb, Himachal Pradesh, and B-1/E-23 Mohan Cooperative Industrial Estate, Mathura Road, New Delhi, serving markets in India and overseas with subsidiaries including JHS Svendgaard Mechanical and Warehouse Private Limited and Jones H Smith FZE in the UAE. Founded in 1997 as Sunehari Svendgaard Laboratories Limited and incorporated on October 8, 2004, it listed on the Bombay Stock Exchange and National Stock Exchange in 2006. In recent developments, the company entered a strategic partnership with US-based GuruNanda in 2025 to expand its global oral care presence; it approved a scheme of amalgamation with Vedic Cosmeceuticals Private Limited effective from April 1, 2024, merging its operations with the latter's skincare portfolio including baby care, hair care, body care, and pet care products for brands like Unilever, Nykaa, and St. Botanica, resulting in a swap ratio of 10 equity shares of Vedic for every 100 of JHS.